RSS-Feed abonnieren

DOI: 10.1055/s-0045-1809903
The Role of Apparent Diffusion Coefficient in Differentiating Benign and Malignant Endometrial Pathologies: A Prospective Single-Center Study
Funding None.

Abstract
Purpose
To investigate the added role of apparent diffusion coefficient (ADC) in differentiating benign from malignant pathologies.
Materials and Methods
Hospital-based random sampling was done and all the females with clinical details suggestive of endometrial pathologies and abnormal ultrasound underwent contrast-enhanced magnetic resonance imaging (MRI). In addition to the routine sequences, imaging was done at different b-values and ADC was calculated. The higher the ADC value the more the chances of benignity. Dynamic contrast-enhanced imaging was also done. Two radiologists with 18 and 10 years of experience evaluated the imaging findings and interobserver agreement was also made. Imaging findings were correlated with diagnosis as made by endometrial aspirate biopsy, dilatation–curettage, or postoperative histopathological examination.
Results
The addition of ADC value and dynamic contrast-enhanced MRI showed a significant role in differentiating benign from malignant conditions. The mean ADC measurement in malignant lesions was 0.88 × 10−3 ± 0.27 × 10−3, whereas the mean ADC measurement for benign lesions was 1.03 × 10−3 ± 0.38 × 10−3. The differences between the two were found to be significant (t-value: 2.754, p-value: 0.014). The cutoff of mean ADC and minimum ADC with the highest sensitivity and specificity were reported to be ≤1 × 10−3 and ≤0.8 × 10−3, respectively.
Conclusion
Adding the ADC value with routine magnetic resonance sequences plays a significant role in differentiating between benign and malignant endometrial pathologies, especially in indeterminate cases
Data Availability Statement
Data are available and will be available on reasonable request.
Authors' Contributions
P.S.: concept and final editing of the manuscript; K.N.: drafting of the manuscript and the images; L.C.: clinical inputs; A.K.: final pathology and providing pathology images; A.S.: drafting of the manuscript; R.K.: statistical analysis
Publikationsverlauf
Artikel online veröffentlicht:
24. Juni 2025
© 2025. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Basaran I, Cengel F, Bayrak AH. Diffusion-weighted imaging in the benign-malignant differentiation of endometrial pathologies; effectiveness of visual evaluation. J Coll Physicians Surg Pak 2023; 33 (01) 73-78
- 2 Maheshwari E, Nougaret S, Stein EB. et al. Update on MRI in evaluation and treatment of endometrial cancer. Radiographics 2022; 42 (07) 2112-2130
- 3 Tamai K, Koyama T, Saga T. et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007; 26 (03) 682-687
- 4 Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188 (06) 1622-1635
- 5 Kierans AS, Bennett GL, Haghighi M, Rosenkrantz AB. Utility of conventional and diffusion-weighted MRI features in distinguishing benign from malignant endometrial lesions. Eur J Radiol 2014; 83 (04) 726-732
- 6 Tamai K, Koyama T, Saga T. et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008; 18 (04) 723-730
- 7 Inoue C, Fujii S, Kaneda S. et al. Correlation of apparent diffusion coefficient value with prognostic parameters of endometrioid carcinoma. J Magn Reson Imaging 2015; 41 (01) 213-219
- 8 Wang J, Yu T, Bai R, Sun H, Zhao X, Li Y. The value of the apparent diffusion coefficient in differentiating stage IA endometrial carcinoma from normal endometrium and benign diseases of the endometrium: initial study at 3-T magnetic resonance scanner. J Comput Assist Tomogr 2010; 34 (03) 332-337
- 9 Neves TR, Correia MT, Serrado MA, Horta M, Caetano AP, Cunha TM. Staging of endometrial cancer using fusion T2-weighted images with diffusion-weighted images: a way to avoid gadolinium?. Cancers (Basel) 2022; 14 (02) 384
- 10 Dhanda S, Thakur M, Kerkar R, Jagmohan P. Diffusion-weighted imaging of gynecologic tumors: diagnostic pearls and potential pitfalls. Radiographics 2014; 34 (05) 1393-1416
- 11 Lane BF, Wong-You-Cheong JJ. Imaging of endometrial pathology. Clin Obstet Gynecol 2009; 52 (01) 57-72
- 12 Elsammak A, Shehata SM, Abulezz M, Gouhar G. Efficiency of diffusion weighted magnetic resonance in differentiation between benign and malignant endometrial lesions. Egypt J Radiol Nucl Med 2017; 48 (03) 751-759
- 13 Bharwani N, Miquel ME, Sahdev A. et al. Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer. Br J Radiol 2011; 84 (1007) 997-1004
- 14 Shen SH, Chiou YY, Wang JH. et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190 (02) 481-488
- 15 Xie M, Ren Z, Bian D. et al. High resolution diffusion-weighted imaging with readout segmentation of long variable echo-trains for determining myometrial invasion in endometrial carcinoma. Cancer Imaging 2020; 20 (01) 66